Abstract
Several transgenic tobacco lines expressing human apolipoprotein A-I (ApoA-I) were obtained. Western blot analyses indicated the expression of the recombinant protein in plant organs at various stages of development, including senescent leaves. A cell line expressing human ApoA-I was established from a T1 transgenic plant. Recombinant ApoA-I was isolated either from extracts of transgenic leaves and from the culture medium of transgenic cells using an antibody-based one-step procedure.
Similar content being viewed by others
References
Dalton MB, Swaney JB (1993) Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J Biol Chem 268:19274–19283
Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14:669–679
de Neve M, De Loose M, Jacobs A, Van Houdt H, Kaluza B, Weidle U, Van Montagu M, Depicker A (1993) Assembly of an antibody and its derived antibody fragment in Nicotiana and Arabidopsis. Transgen Res 2:227–237
Desai PN, Shrivastava N, Padh H (2010) Production of heterologous proteins in plants: strategies for optimal expression. Biotechnol Adv 28:427–435
Edwards K, Johnstone C, Thompson C (1991) A simple and rapid method for the preparation of plant genomic DNA for PCR analysis. Nucleic Acids Res 19:1349
Gordon J, Sims H, Lentz S, Edelstein C, Scanu A, Strauss A (1983) Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier’s disease. J Biol Chem 258:4037–4044
Horsch RB, Fry JE, Hoffmann NL, Eichholtz D, Rogers SG, Fraley RT (1985) A simple and general method for transferring genes into plants. Science 227:1229–1231
Khoudi H, Laberge S, Ferullo J-M, Bazin R, Darveau A, Castonguay Y, Allard G, Lemieux R, Vézina L-P (1999) Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotechnol Bioeng 64:135–143
Kimchi-Sarfaty C, Oh JM, Kim I-W, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–528
Menassa R, Du C, Yin ZQ, Ma S, Poussier P, Brandle J, Jevnikar AM (2007) Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis. Plant Biotechnol J 5:50–59
Murashige T, Skoog F (1962) A revised medium for rapid growth and bio-assays with tobacco tissue cultures. Physiol Plant 15:473–497
Nagel R, Manners J, Birch R (1992) Evaluation of an ELISA assay for rapid detection and quantification of neomycin phosphotransferase II in transgenic plants. Plant Mol Biol Rep 10:263–272
Nissen SE et al (2003) Effect of recombinant ApoA-I milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. J Am Med Assoc 290:2292–2300
Schardl CL, Byrd AD, Benzion G, Altschuler MA, Hildebrand DF, Hunt AG (1987) Design and construction of a versatile system for the expression of foreign genes in plants. Gene 61:1–11
Schillberg S, Emans N, Fischer R (2002) Antibody molecular farming in plants and plant cells. Phytochem Rev 1:45–54
Schmidt HH, Haas RE, Remaley A, Genschel J, Strassburg CP, Buttner C, Manns MP (1997) In vivo kinetics as a sensitive method for testing physiologically intact human recombinant apolipoprotein A-I: comparison of three different expression systems. Clin Chim Acta 268:41–60
Stevens LH, Stoopen GM, Elbers IJW, Molthoff JW, Bakker HAC, Lommen A, Bosch D, Jordi W (2000) Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco. Plant Physiol 124:173–182
Suo G, Chen B, Zhang J, Gao Y, Wang X, He Z, Dai J (2006) Expression of active hBMP2 in transgenic tobacco plants. Plant Cell Rep 25:1316–1324
Tiwari S, Verma PC, Singh PK, Tuli R (2009) Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 27:449–467
Tremblay R, Wang D, Jevnikar AM, Ma S (2010) Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol Adv 28:214–221
Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM (2006) Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Arterioscler Thromb Vasc Biol 26:1572–1578
Zannis VI, Karathanasis SK, Keutmann HT, Goldberger G, Breslow JL (1983) Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide. Proc Natl Acad Sci USA 80:2574–2578
Zavala G, Cheng S (2006) Experimental infection with avian leukosis virus isolated from Marek’s disease vaccines. Avian Dis 50:232–237
Zhong G-Y et al (1999) Commercial production of aprotinin in transgenic maize seeds. Mol Breed 5:345–356
Acknowledgments
The authors wish to thank Dr Maria Teresa Valente for valuable help in the production of transgenic tobacco plants and Mrs Sara Siervo for technical assistance. This research was supported by grants from the Ministry of University and Research, Italy (PRIN Program 2007), entitled “Plant-based production of recombinant proteins for diagnosis and therapy of human diseases” and “Protein misfolding and amyloid”.
Author information
Authors and Affiliations
Corresponding author
Additional information
Purpose of work
Apolipoprotein A-I (ApoA-I), the major component of plasma high-density lipoproteins, plays a pivotal role in preventing atherosclerosis development, being involved in the transport of cholesterol from peripheral cells to the liver where it is degraded. In this study, plants and plant cells cultures are suggested as suitable platforms for the production of ApoA-I for therapeutic or analytical purposes.
Pasquale Chiaiese, Maria Minutolo contributed equally to this work.
An erratum to this article can be found at http://dx.doi.org/10.1007/s10529-010-0441-3
Rights and permissions
About this article
Cite this article
Chiaiese, P., Minutolo, M., Arciello, A. et al. Expression of human apolipoprotein A-I in Nicotiana tabacum . Biotechnol Lett 33, 159–165 (2011). https://doi.org/10.1007/s10529-010-0388-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-010-0388-4